Yardley, PA, United States of America

William J Garner

USPTO Granted Patents = 17 

 


Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 49(Granted Patents)


Location History:

  • Yardley, PA (US) (1990 - 2001)
  • San Francisco, CA (US) (2017 - 2021)
  • San Juan, PR (US) (2021)

Company Filing History:


Years Active: 1990-2021

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovations of William J Garner

Introduction

William J Garner is a notable inventor based in Yardley, PA (US), recognized for his significant contributions to the field of therapeutic agents. With a total of 17 patents to his name, Garner has focused on improving the efficacy of treatments for various malignancies.

Latest Patents

Garner's latest patents include innovative methods and compositions aimed at enhancing the therapeutic benefit of bisantrene and its analogs and derivatives. These inventions describe techniques for improving the therapeutic efficacy of agents that have previously been limited by suboptimal performance. By either enhancing efficacy as a monotherapy or reducing side effects, these methods are particularly applicable to bisantrene and its derivatives, analogs, or prodrugs. Such advancements are crucial for the treatment of malignancies, showcasing Garner's commitment to improving patient outcomes.

Career Highlights

Throughout his career, William J Garner has worked with prominent companies such as Lucent Technologies Inc. and Race Oncology Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of therapeutic methods.

Collaborations

Garner has collaborated with notable individuals in his field, including John Rothman and Winston Hong Lieu. These partnerships have likely played a role in the development of his patents and the enhancement of therapeutic strategies.

Conclusion

William J Garner's work exemplifies the impact of innovation in the medical field, particularly in the development of therapies for malignancies. His patents reflect a dedication to improving therapeutic efficacy and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…